{
    "name": "cysteamine ophthalmic",
    "comment": "Rx",
    "other_names": [
        "Cystaran",
        "Cystadrops"
    ],
    "classes": [
        "Ophthalmics",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/cystaran-cystadrops-cysteamine-ophthalmic-999777",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies of ophthalmic cysteamine in pregnant females to inform any drug associated risks"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Oral administration of cysteamine to pregnant rats throughout organogenesis was teratogenic at doses 240 to 960 times the recommended human ophthalmic dose (based on body surface area)",
                    "Use during pregnancy only if potential benefit justifies potential risk to the fetus"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No information available regarding presence of cysteamine in human milk, the effects on the breastfed infants, or the effects on milk production",
            "Cysteamine administered orally is present in milk of lactating rats",
            "Unknown whether measurable levels of cysteamine would be present in maternal milk following topical ocular administration"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Sensitivity to light",
            "percent": null
        },
        {
            "name": "Redness",
            "percent": null
        },
        {
            "name": "Eye pain",
            "percent": null
        },
        {
            "name": "irritation",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Visual field defects",
            "percent": null
        },
        {
            "name": "Eye pain",
            "percent": null
        },
        {
            "name": "Vision blurred",
            "percent": null
        },
        {
            "name": "Eye irritation",
            "percent": null
        },
        {
            "name": "Ocular hyperemia",
            "percent": null
        },
        {
            "name": "Instillation site discomfort",
            "percent": null
        },
        {
            "name": "Eye pruritus",
            "percent": null
        },
        {
            "name": "Lacrimation increased",
            "percent": null
        },
        {
            "name": "Ocular deposits",
            "percent": null
        }
    ]
}